• Register
  • Login

Iraqi Postgraduate Medical Journal

  1. Home
  2. Evaluation of Hepcidin and Interleukin-6 in Patients with Beta-Thalassemia Major

Current Issue

By Issue

By Author

By Subject

Author Index

Keyword Index

Copyrights and Licensing

Home

About Journal

Aim and Scope

Editorial Board

Peer Review Process

Copyrights and Licensing

Indexing and Abstracting

Plagiarism Policy

Author's Guide

Article processing charge (APC)

Evaluation of Hepcidin and Interleukin-6 in Patients with Beta-Thalassemia Major

    Authors

    • Hiba Milhim Fathi
    • Muna Abdulbasit kashmoola

    University of Mousl

,

Document Type : Research Paper

10.52573/ipmj.2025.147545
  • Article Information
  • References
  • Download
  • Export Citation
  • Statistics
  • Share

Abstract

Background: In β- thalassemia major, irregularly transfused patients, hepcidin usually high due to increased iron load and the alleviation of ineffective erythropoiesis; rather than regularly transfused patients. Elevation of interleukin-6 in β- thalassemia had been reported in few theses.

Aim of the study: To evaluate the level of serum hepcidin, interleukin-6 and ferritin in patients with β-thalassemia

Materials and Methods: This was a case control study conducted at thalassemia center of Ibn Al-Atheer Teaching Hospital in Nineveh Province during a period of six months between February and August 2022. It included 180 participants divided into two groups: Case group included 90 patients diagnosed as β-thalassemia major, aged between 5 - 40 years and control group included 90 healthy persons matched in age and gender to the case group.

Results: In this study, means of IL-6, hepcidin, and ferritin were significantly higher with P-value(0.001 , 0.001 , 0.001) respectively, while mean of Hb was significantly lower with P-value(0.001) in case group than that in controls. Strong negative correlation detected between ferritin and hepcidin, weak negative correlation found between ferritin and IL-6, and weak positive correlation between hepcidin and IL-6.

Conclusions: Iron overload and alleviation of ineffective erythropoiesis made Hepcidin, interleukin-6 and ferritin higher in β-thalassemia major patients. Hepcidin and interleukin-6 levels have significant inverse correlation with serum level of ferritin. There was direct linear relationship between Interleukin-6 and hepcidin.

Keywords

  • Keywords: β - thalassemia major
  • hepcidin
  • interleukin-6
  • ferritin
  • transfusion

Main Subjects

  • Pathology/ Haematology
  • XML
  • PDF 272.04 K
  • RIS
  • EndNote
  • Mendeley
  • BibTeX
  • APA
  • MLA
  • HARVARD
  • VANCOUVER
References
 1. Vargas-Hernández DA, Uscategui-Ruiz AC, De
Avila J, Romero-Sánchez C. Differences in the
distribution of hemoglobin variants according
to the geographic regions in a Colombian
population. Hematology, Transfusion and Cell
Therapy. 2023.
2. Lee JS, Cho SI, Park SS, Seong MW.
Molecular basis and diagnosis of thalassemia.
Blood research. 2021;56(S1):S39-s43.
3. Chaichompoo P, Svasti S, Smith DR. The
Roles of Mitophagy and Autophagy in
Ineffective Erythropoiesis in β-Thalassemia.
International Journal of Molecular Sciences.
2022;23(18):10811.
4. Galanello R, Origa R. Beta-thalassemia.
Orphanet journal of rare diseases. 2010;5:11.
5. Camaschella C, Nai A. Ineffective
erythropoiesis and regulation of iron status in
iron loading anaemias. British journal of
haematology. 2016;172(4):512-23.
6. Nemeth E, Ganz T. Hepcidin and iron in health
and disease. Annual review of medicine.
2023;74:261 -77.
7. Kontoghiorghe CN, Kontoghiorghes GJ.
Efficacy and safety of iron-chelation therapy
with deferoxamine, deferiprone, and
deferasirox for the treatment of iron-loaded
patients with non-transfusion-dependent
thalassemia syndromes. Drug Design,
Development and Therapy. 2016:465-81.
8. Coates TD. Iron overload in transfusiondependent patients. Hematology 2014, the
American Society of Hematology Education
Program Book. 2019;2019(1):337-44.
9. Aliyu M, Zohora FT, Anka AU, Ali K,
Maleknia S, Saffarioun M, et al. Interleukin-6
cytokine: An overview of the immune
regulation, immune dysregulation, and
therapeutic approach. International
Immunopharmacology. 2022;111:109130.
10. Caprari P, Profumo E, Massimi S, Buttari B,
Riganò R, Regine V, et al. Hemorheological
profiles and chronic inflammation markers in
transfusion-dependent and non-transfusiondependent thalassemia. Frontiers in Molecular
Biosciences. 2023;9:1108896.
 11. Nemeth E. Hepcidin in beta-thalassemia.
Annals of the New York Academy of Sciences.
2010;1202:31 -5.
12. Salama Kh, Ibrahim O, Kaddah A, Boselia S,
Ismail L, Hamid M. Liver Enzymes with betaThalassemia Major: Corelation with Iron
Overload and Viral
Hepatitis.NIH.2015;3(2):287-92.
    • Article View: 244
    • PDF Download: 93
Iraqi Postgraduate Medical Journal
Volume 24, Issue 2
April 2025
Page 181-184
Files
  • XML
  • PDF 272.04 K
Share
Export Citation
  • RIS
  • EndNote
  • Mendeley
  • BibTeX
  • APA
  • MLA
  • HARVARD
  • VANCOUVER
Statistics
  • Article View: 244
  • PDF Download: 93

APA

Fathi, H., & kashmoola, M. (2025). Evaluation of Hepcidin and Interleukin-6 in Patients with Beta-Thalassemia Major. Iraqi Postgraduate Medical Journal, 24(2), 181-184. doi: 10.52573/ipmj.2025.147545

MLA

Hiba Milhim Fathi; Muna Abdulbasit kashmoola. "Evaluation of Hepcidin and Interleukin-6 in Patients with Beta-Thalassemia Major". Iraqi Postgraduate Medical Journal, 24, 2, 2025, 181-184. doi: 10.52573/ipmj.2025.147545

HARVARD

Fathi, H., kashmoola, M. (2025). 'Evaluation of Hepcidin and Interleukin-6 in Patients with Beta-Thalassemia Major', Iraqi Postgraduate Medical Journal, 24(2), pp. 181-184. doi: 10.52573/ipmj.2025.147545

VANCOUVER

Fathi, H., kashmoola, M. Evaluation of Hepcidin and Interleukin-6 in Patients with Beta-Thalassemia Major. Iraqi Postgraduate Medical Journal, 2025; 24(2): 181-184. doi: 10.52573/ipmj.2025.147545

  • Home
  • About Journal
  • Editorial Board
  • Submit Manuscript
  • Contact Us
  • Glossary
  • Sitemap

News

This work is licensed under          CC BY 4.0    

 

 

Newsletter Subscription

Subscribe to the journal newsletter and receive the latest news and updates

© Journal Management System. Powered by iJournalPro.com